<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Splenic marginal zone <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZLs</z:e>) have been found to occur at a high frequency in NFS.N mice congenic for high-expressing ecotropic murine <z:hpo ids='HP_0001909'>leukemia</z:hpo> virus (MuLV) genes from AKR and C58 mice </plain></SENT>
<SENT sid="1" pm="."><plain>Based on morphological, immunological, and molecular studies of these mice, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> is clearly recognizable as a distinct disease with a characteristic clinical behavior </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> was staged according to the degree of accumulation and morphological change of cells within the splenic marginal zone, as follows: 1) a moderate increase in <z:mpath ids='MPATH_458'>normal</z:mpath>-looking MZ cells, judged to be prelymphomatous, and 2) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> in three variants: i) distinct enlargement of MZ by <z:mpath ids='MPATH_458'>normal</z:mpath>-looking cells (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e>), ii) distinct enlargement of MZ by basophilic centroblast-like cells (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e>+), and iii) extensive splenic involvement by centroblast-like cells (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e>++) </plain></SENT>
<SENT sid="3" pm="."><plain>The rate of mitosis and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> increases with <z:hpo ids='HP_0002665'>lymphoma</z:hpo> grade </plain></SENT>
<SENT sid="4" pm="."><plain>In most cases, emergence of a dominant IgH clonal pattern in paired splenic biopsy and necropsy samples was correlated with progression </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZLs</z:e> were transplantable and homed to the spleen </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> may constitute a commonly occurring <z:hpo ids='HP_0002665'>lymphoma</z:hpo> type unrecognized, in part, because of the <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> <z:mp ids='MP_0000002'>morphology</z:mp> of high-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> and possible <z:hpo ids='HP_0001548'>overgrowth</z:hpo> of lower-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> by more aggressive follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>